Ticker Scorecard - LAB Basics Company: Standard BioTools Inc. IPO Date: March 1, 2011 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $483.94M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.53% Avg Daily Range (30 D): $0.06 | 3.81% Avg Daily Range (90 D): $0.07 | 3.73% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): 1.74M Avg Daily Volume (90 D): 1.61M Trade Size Avg Trade Size (Sh.): 180 Avg Trade Size (Sh.) (30 D): 218 Avg Trade Size (Sh.) (90 D): 205 Institutional Trades Total Inst.Trades: 109 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $3.43M Avg Inst. Trade (90 D): $1.26M Avg Inst. Trade Volume: .9M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.24M Avg Closing Trade (30 D): $6.24M Avg Closing Trade (90 D): $1.8M Avg Closing Volume: 1.69M     News Jan 13, 2025 @ 12:00 PM Standard BioTools Announces Preliminary Fourth Qua... Source: N/A Dec 19, 2024 @ 1:00 PM Standard BioTools to Present at the 43rd Annual J.... Source: N/A Nov 7, 2024 @ 1:00 PM Standard BioTools Appoints Alex Kim as Chief Finan... Source: Standard Biotools Inc. Oct 16, 2024 @ 12:00 PM Standard BioTools Announces Conference Call and We... Source: N/A Jun 27, 2024 @ 9:30 PM Labrador Gold Shareholders Approve Sale of Kingswa... Source: Labrador Gold Corp. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.07 $-.12 $-.27 Diluted EPS $-.07 $-.12 $-.27 Revenue $ 44.97M $ 37.21M $ 45.54M Gross Profit $ 23.26M $ 14.91M $ 24.19M Net Income / Loss $ -26.94M $ -45.72M $ -32.16M Operating Income / Loss $ -31.72M $ -50.52M $ -60.18M Cost of Revenue $ 21.71M $ 22.3M $ 21.35M Net Cash Flow $ -59.16M $ -17.24M $ 235.85M PE Ratio